ASX:OCC Orthocell (OCC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Orthocell Stock (ASX:OCC) 30 days 90 days 365 days Advanced Chart Get Orthocell alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume669,530 shsAverage VolumeN/AMarket CapitalizationA$375.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia. Read More Receive OCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orthocell and its competitors with MarketBeat's FREE daily newsletter. Email Address OCC Stock News HeadlinesWhich ASX All Ords stock is jumping on record quarter?June 30, 2025 | msn.comGuess which ASX All Ords stock is jumping 9% on $1.6b market opportunityJune 26, 2025 | msn.comTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. | Paradigm Press (Ad)Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?June 26, 2025 | msn.comHealth Check: On Garfield the Cat Day, the biotech sector purrs with deals and breakthroughsJune 19, 2025 | msn.comOrthocell sets new benchmark in nerve repairJune 19, 2025 | msn.comOrthocell’s Remplir Outperforms Standard Nerve Repair Techniques in New StudyJune 18, 2025 | tipranks.comOrthocell grows US distributors for nerve repair product to 12May 15, 2025 | msn.comSee More Headlines OCC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Orthocell own? Based on aggregate information from My MarketBeat watchlists, some other companies that Orthocell investors own include Plug Power (PLUG), Viralytics (VRACY), Genetic Technologies (GTG) and GP Strategies (GPX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustrySteel Works Current SymbolASX:OCC CIKN/A Webwww.orthocell.com.au Phone61 8 9360 2888FaxN/AEmployees340Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$7.18 million Net Margins-111.03% Pretax MarginN/A Return on Equity-214.01% Return on Assets-25.04% Debt Debt-to-Equity Ratio15.22 Current Ratio4.34 Quick Ratio5.07 Sales & Book Value Annual SalesA$5.32 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.41 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares209,580,000Free FloatN/AMarket CapA$375.52 million OptionableNot Optionable Beta1.16 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (ASX:OCC) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthocell Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthocell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCC Stock Alerts